New York State Teachers Retirement System Sells 9,498 Shares of DaVita Inc. (NYSE:DVA)

New York State Teachers Retirement System reduced its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 19.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 39,940 shares of the company's stock after selling 9,498 shares during the quarter. New York State Teachers Retirement System's holdings in DaVita were worth $6,110,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in DVA. Epoch Investment Partners Inc. acquired a new stake in shares of DaVita during the fourth quarter worth approximately $55,100,000. Invesco Ltd. grew its position in shares of DaVita by 20.9% in the 4th quarter. Invesco Ltd. now owns 1,589,545 shares of the company's stock valued at $237,716,000 after purchasing an additional 275,284 shares during the period. Iron Triangle Partners LP acquired a new stake in shares of DaVita in the 4th quarter valued at approximately $38,946,000. Amundi lifted its position in DaVita by 116.4% during the fourth quarter. Amundi now owns 446,386 shares of the company's stock worth $68,726,000 after acquiring an additional 240,126 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in DaVita by 14,695.8% in the 1st quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock worth $35,919,000 after purchasing an additional 233,222 shares in the last quarter. Institutional investors own 90.12% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently commented on DVA. Truist Financial lowered their price target on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, DaVita presently has a consensus rating of "Hold" and an average price target of $164.50.

DaVita Trading Up 0.5%

DVA stock traded up $0.73 during midday trading on Monday, hitting $143.29. The company had a trading volume of 90,717 shares, compared to its average volume of 806,291. The stock's 50 day moving average price is $140.06 and its 200 day moving average price is $149.26. DaVita Inc. has a 52 week low of $131.76 and a 52 week high of $179.60. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18. The stock has a market cap of $10.82 billion, a price-to-earnings ratio of 14.18, a PEG ratio of 0.98 and a beta of 1.11.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same quarter in the prior year, the company earned $2.26 EPS. The business's revenue was up 5.0% compared to the same quarter last year. As a group, equities research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.